We are Sorry, This Page doesn't Exist
Fortress Biotech reports Q1 EPS (11c), consensus (16c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Fortress Biotech options imply 25.5% move in share price post-earnings
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Fortress Biotech enters license agreement with Fuji Yakuhin for Dotinurad
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Fortress Biotech management to meet virtually with B. Riley
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Fortress Biotech weakness yesterday a buying opportunity, says B. Riley
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Fortress Biotech price target raised to $9 from $8 at B. Riley
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Fortress Biotech partner Journey Medical enters $7.5M line of credit agreement
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Fortress Biotech partner Journey Medical to acquire QBREXA from Dermira
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Fortress Biotech reports FY20 EPS (18c), consensus (73c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Fortress Biotech partner Journey Medical in-licenses Accutane for nodular acne
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Fortress Biotech price target raised to $21 from $16 at Dawson James
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Fortress Biotech reports Q1 EPS (28c), consensus (24c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Fortress Biotech announces $5M preferred stock repurchase program
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Fortress Biotech management to meet with B. Riley FBR
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Fortress Biotech Reports Record Fourth Quarter and Full-Year 2019 Financial Results and Recent Corporate Highlights
Revenue from marketed dermatology products increased 85% for fourth quarter 2019 and 49% for full-year 2019 compared to 2018 NDA for IV tramadol accepted .....»»
Fortress Biotech initiated with an Overweight at Cantor Fitzgerald
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Fortress Biotech prices 625,000 series A preferred shares at $20
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Fortress Biotech announces Rare Pediatric Disease Designation for CUTX-101
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Cincinnati Children’s strikes deal with pharma firms
Cincinnati Children’s Hospital has entered into an agreement to advance clinical development of a medicine that involves several pharmaceutical firms. Fortress Biotech Inc. disclosed today that Baergic Bio Inc., a newly formed Fortress partner .....»»
Fortress Biotech announces agreements with AstraZeneca, Cincinnati Children"s
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»